Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Locally Advanced Breast Cancer × Clinical Protocols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Locally Advanced Breast Cancer 1 Leukemia, Myeloid, Acute 1 Endometrial Neoplasms 1

Interventions

pertuzumab 1 Paclitaxel 1 Clinical Protocols 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05749016 2023-03-01

Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Unknown

Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡